Kina 3415-08-5 L-Tyr-NCA Mea Hana a hale hana |Jiayinglai

3415-08-5 L-Tyr-NCA

ʻO ka wehewehe pōkole:

Ka nana aku	ʻO ke keʻokeʻo a i ʻole keʻokeʻo keʻokeʻo a i ʻole ka pauka crystalline
MF	C10H9NO4
MW	207.18
Maemae	98+

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

ʻO ke kūlana kaʻaahi a me ke ʻano hoʻouna i ʻōlelo ʻia:
ma ka lewa, ma ke kai a ma ke ala pololei

Kūlana mālama:
nert lewa, E mālama i loko o ka pahu hau, ma lalo o -20°C

Ka nui o ke kauoha liʻiliʻi:
Kūkākūkā

palapala hōʻoia:
COA, HPLC, GC, HNMR, Assay, Water Content(KF), TLC loaʻa

Nā huaʻōlelo like

Tirosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Hoʻopili i loko

Hoʻohana mau ʻia lākou no ka ʻeke pauda.A hiki iā lākou ke pale i ka lā a me ka wai mai ka pōʻino.

kāʻei waho

Hiki i ka pahu paʻakikī ke pale i kāu huahana mai ka hāʻule a pulu.

Nā noi

ʻO 3415-08-5 L-Tyr-NCA kekahi o nā mea waena o Glatiramer Acetate.

ʻO Glatiramer Acetate kahi mea peptide synthetically i hoʻomākaukau ʻia i ʻehā amino acids: glutamic acid, alanine, tyrosine, a me lysine.Aia kāna noi mua i ka mālama ʻana i ka Multiple Sclerosis (MS), kahi maʻi maʻi maʻi, inflammatory, demyelinating e pili ana i ka ʻōnaehana nerve waena.Ma o ke ʻano o ka "bypass suppression," hoʻohana ʻo Glatiramer Acetate i ka immunomodulatory a me nā hopena anti-inflammatory i MS, e hoʻonui ana i nā pae o ka brain-derived neurotrophic factor (BDNF), hoʻohaʻahaʻa i ka demyelination i hoʻoulu ʻia i ka mumū, a me ka hoʻoulu ʻana i ka ulu ʻana o nā axons a me myelin sheaths.

Ma ke ao holoʻokoʻa, ua loaʻa iā Glatiramer Acetate ka noi ākea.No ka laʻana, ma ʻAmelika Hui Pū ʻIa, kūʻai ʻia ma lalo o ka inoa inoa Copaxone a ua ʻae ʻia e ka Food and Drug Administration (FDA) no ka mālama ʻana i ka Multiple Sclerosis.I nā ʻāina Komohana me kahi kiʻekiʻe o MS, ua ʻike nui ʻia kona pono a me ka hoʻomanawanui.

Ma Kina, ma Iune 28, 2023, "Glatiramer Acetate Injection" loaʻa ka ʻae ʻia mai ka National Medical Products Administration (NMPA) no ka mālama ʻana i nā poʻe maʻi maʻi me ka hoʻihoʻi hou ʻana i ka Multiple Sclerosis (MS), me ka maʻi i hoʻokaʻawale ʻia i ka maʻi, relapsing-remitting. MS, a me MS holomua holomua lua.

huahana pili

L-Gly-NCA	L-Ala-NCA	D-Ala-NCA	L-Val-NCA
D-Leu-NCA	DL-leu-NCA	L-Phe-NCA	D-Tyr-NCA
L-Tyr(bzl)-NCA	L-Glu(Obzl)-NCA	D-Asp(OBzl)-NCA	L-Lys(tfa)-NCA
L-Lys(Cbz)-NCA	D-Lys(Cbz)-NCA	Sar-NCA

Kiekie

1. Loaʻa ka lawelawe R&D
2. ʻO ka mea hana i hōʻoia ʻia ʻo ISO, hōʻoia maikaʻi
3.A piha piha o ka lawelawe ukali i ka wā hana
4.High kumu kūʻai pono
Nā palapala hōʻoia 5.Quality i hāʻawiʻia no ka noi a ka mea kūʻai
6.Great ma hope o ke kūʻai aku, mālama i ka pilina pili me ka mea kūʻai
7.Full punawai e kōkua i ka ho'ēmiʻana i ke kumukūʻai moku
8.Free hāpana hāʻawi ʻia e nānā i ka maikaʻi ma mua o kekahi uku
9.Payment manawa kūkākūkā
10.Assit nā mea kūʻai aku e pili ana i nā hihia ma Kina